Collaborative project of more than $1.2 million using artificial intelligence to optimize the production of vaccines
The biopharmaceutical research consortium CQDM and Medicago R&D are proud to announce today the funding of a research project that will allow the Quebec City-based company to increase the competitiveness of its vaccine production platform and confirm its position as leader in the biopharmaceutical industry in Canada. Through CQDM, the Ministry of Economy and Innovation of Quebec is providing a grant of $500,000 for the implementation of this three-year initiative.
“The health crisis resulting from COVID-19 highlights the importance of producing vaccines to ensure the protection and health of the population. The Quebec Government feels that it’s more important than ever to support this research project, which will give Medicago, a key player in the biopharmaceutical industry, the means to increase its productivity by leveraging artificial intelligence. In doing so, we are also strengthening Québec’s position as world-class vaccine manufacturing hub,” noted Pierre Fitzgibbon, Minister of the Economy and Innovation.
The project is led by the team of Professor Jacques Corbeil, researcher at the Department of Molecular Medicine at the CHU de Québec-Laval University, and carried out in close collaboration with Medicago R&D. Professor Corbeil is internationally renowned for his expertise in the interface of medicine and machine learning approaches. He holds the tier 1 Canada Research Chair in Medical Genomics.
“It is important to mention that this project was born out of a common desire to improve vaccine production in order to better protect the health of Canadians. This strong support is particularly timely to lead our fight against the emerging diseases we face today, such as COVID-19 right now”, said Professor Corbeil.